Primary objective is to assess whether 2 g IV magnesium sulfate reduces hypoxia during OLV in thoracotomy.
Secondary objectives include evaluating severity and duration of hypoxia, hemodynamic and EtCO₂ changes, and adverse events.
Design
A randomized, double‑blind
Settings and conduct
Patients are randomly assigned using sealed envelopes. Study conducted at a university thoracic surgery center.
Participants/Inclusion and exclusion criteria
Inclusion: adults 18–65 undergoing elective thoracotomy with OLV. Exclusion: pregnancy, magnesium allergy, severe cardiac/renal failure.
Intervention groups
Intervention group receives 2 g magnesium sulfate IV after induction; control receives equal volume of normal saline.
Main outcome variables
Primary outcome is incidence of hypoxia (SpO₂ < 90%); secondary outcomes include hemodynamic and EtCO₂ changes.
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20250923067343N4
Registration date:2026-06-05, 1405/03/15
Registration timing:prospective
Last update:2026-06-05, 1405/03/15
Update count:0
Registration date
2026-06-05, 1405/03/15
Registrant information
Name
kobra Rafiei badi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2269 0414
Email address
abrisham57@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-06-22, 1405/04/01
Expected recruitment end date
2026-09-22, 1405/06/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of Intravenous Magnesium Sulfate Administration on Reducing Intraoperative Hypoxia in Patients Undergoing Thoracotomy
Public title
Effect of Magnesium Sulfate on Reducing Oxygen Desaturation During Chest Surgery.
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
informed consent
Age 18 to 65 years
ASA class I–III
Candidate for elective thoracotomy Requirement for one‑lung ventilation (OLV).
Exclusion criteria:
Severe cardiac or renal failure
History of magnesium hypersensitivity
Pregnancy
Intraoperative termination of surgery or inability to continue OLV due to unexpected causes
Need for urgent change in the anesthesia technique
Age
From 18 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Data analyser
Sample size
Target sample size:
70
Randomization (investigator's opinion)
Randomized
Randomization description
Method: Block randomization with blocks of four
Allocation ratio: 1:1
Software: Random Allocation Software
Allocation concealment: Sequentially numbered, opaque, sealed envelopes (SNOSE)
Blinding (investigator's opinion)
Double blinded
Blinding description
This study is designed as a double-blind clinical trial. To maintain blinding, the intervention solution (magnesium sulfate) and the placebo (normal saline) will be prepared by a third party (pharmacist or research nurse) in syringes identical in appearance, volume, and color. All solutions will be administered at the same rate and timing. Group allocation will be performed using a computer-generated random sequence with proper allocation concealment. Throughout the study, the patients, anesthesiologists, surgical team, and outcome assessors will remain unaware of the assigned intervention in order to minimize the risk of bias.
In the intervention group, 2 g of intravenous magnesium sulfate diluted in 100 mL of normal saline is administered immediately after anesthesia induction over 15–20 minutes.
Category
Treatment - Drugs
2
Description
Control group: In the control group, 100 mL of normal saline is administered intravenously immediately after anesthesia induction over 15–20 minutes. The appearance, volume, and method of administration are identical to the intervention group to maintain blinding.
Category
Treatment - Devices
Recruitment centers
1
Recruitment center
Name of recruitment center
Masih Daneshvari Hospital
Full name of responsible person
Kobra Rafiei Badi
Street address
Masih Daneshvari Hospital, Imam Hassan Building, 10th Floor, Department of Anesthesiology, Darabad, Shahid Bahonar Street, Tehran, Iran